Dialogues in Clinical Neuroscience · 2011 · 811 citations · 21 references
Public HealthInternal MedicineEvidence-based PracticeExperimental DesignPragmaticsClinical PragmaticsClinical Trial DesignClinical Trial EthicsClinical TrialsStudy DesignTrial ProcedureExplanatory Clinical TrialsExploratory Clinical TrialsPragmatic Trial Design
Clinical trials are the primary tool for evaluating interventions, and pragmatic trials—designed to assess effectiveness in routine practice—have gained traction because they yield generalizable results unlike explanatory trials that test interventions under optimal conditions. This review outlines the continuum between pragmatic and explanatory trials, discusses the limitations of pragmatic designs, and highlights their impact on medical practice.
Clinical trials have been the main tool used by the health sciences community to test and evaluate interventions. Trials can fall into two broad categories: pragmatic and explanatory. Pragmatic trials are designed to evaluate the effectiveness of interventions in real-life routine practice conditions, whereas explanatory trials aim to test whether an intervention works under optimal situations. Pragmatic trials produce results that can be generalized and applied in routine practice settings. Since most results from exploratory trials fail to be broadly generalizable, the "pragmatic design" has gained momentum. This review describes the concept of pragmatism, and explains in particular that there is a continuum between pragmatic and explanatory trials, rather than a dichotomy. Special focus is put on the limitations of the pragmatic trials, while recognizing the importance for and impact of this design on medical practice.
21
Improving the reporting of pragmatic trials: an extension of the CONSORT statement
Merrick Zwarenstein, Shaun Treweek, Joel Gagnier et al. · BMJ · 2008 · 1.8K citations · Full text